Three-year follow-up of the ARTS-II# - sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease.

@article{Serruys2008ThreeyearFO,
  title={Three-year follow-up of the ARTS-II# - sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease.},
  author={Patrick W. Serruys and Joost Daemen and Marie-claude Morice and Bernard De Bruyne and Antonio Colombo and Carlos M Macaya and Gert H Richardt and Jean Fajadet and C. W. Hamm and Keith D. Dawkins and Pascal Vranckx and Marco A. J. J. Bressers and Ron Theodoor van Domburg and Monique Schuijer and Kristel Wittebols and Magdaleen Pieters and Hans Peter Stoll},
  journal={EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology},
  year={2008},
  volume={3 4},
  pages={450-9}
}
AIMS Late stent thrombosis has been documented in on- and off-label populations. Stent thrombosis is more frequently in higher risk patients and there is still scarce data about the impact on late adverse cardiac events. The aim therefore is to determine the 3-year safety and effectiveness of Sirolimus-Eluting Stent (SES) (Cypher(R)) implantation in patients with multivessel disease and to compare outcomes with the historical results of the two arms of the Arterial Revascularisation Therapies… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

Coronary stents: current status.

Journal of the American College of Cardiology • 2010

Similar Papers

Loading similar papers…